Aminolevulinic Acid Photodynamic Therapy for Skin Cancers

Dermatologic Clinics

Volumn 25, Issue 1, 2007, Pages 5-14

  Blume, Jonathan E ^a   Oseroff, Allan R ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ANALGESIC AGENT; BENZOPORPHYRIN DERIVATIVE; EMLA; FLUOROURACIL; PHOTOFRIN; WATER;

ACTINIC KERATOSIS; APPLICATION SITE BURNING; APPLICATION SITE DISCOMFORT; APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE HYPERPIGMENTATION; APPLICATION SITE PAIN; APPLICATION SITE PRURITUS; BARRETT ESOPHAGUS; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER ADJUVANT THERAPY; CANCER CYTODIAGNOSIS; CANCER INFILTRATION; CANCER INVASION; CANCER PREVENTION; CHEMOSURGERY; CHROMOSOME ABERRATION; CRYOTHERAPY; DENTAL ANESTHESIA; DNA ALKYLATION; DNA STRAND BREAKAGE; DRUG ACTIVITY; DRUG MECHANISM; DRUG PENETRATION; DRUG SELECTIVITY; DRUG TOLERABILITY; EARLY CANCER; ESOPHAGUS CANCER; HIGH RISK PATIENT; HISTORY OF MEDICINE; HUMAN; HYPOPIGMENTATION; IONTOPHORESIS; LUNG CANCER; MUTAGENIC ACTIVITY; MYCOSIS FUNGOIDES; PATIENT MONITORING; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; RED LIGHT; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SKIN LYMPHOMA; STRATUM CORNEUM;

AMINOLEVULINIC ACID; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 33751265487     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2006.09.005     Document Type: Review

References (56)

1. Peng Q., Warloe T., Berg K., et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79 12 (1997) 2282-2308
2. Morton C., Brown S., Collins S., et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Derm 146 (2002) 552-567
3. Zeitouni N.C., Oseroff A.R., and Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol 39 17-18 (2003) 1133-1136
4. Marmur E.S., Schmults C.D., and Goldberg D.J. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 30 2 Pt 2 (2004) 264-271
5. Kormeili T., Yamauchi P.S., and Lowe N.J. Topical photodynamic therapy in clinical dermatology. Br J Dermatol 150 6 (2004) 1061-1069
6. Babilas P., Karrer S., Sidoroff A., et al. Photodynamic therapy in dermatology-an update. Photodermatol Photoimmunol Photomed 21 3 (2005) 142-149
7. Garcia-Zuazaga J., Cooper K.D., and Baron E.D. Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer. Expert Rev Anticancer Ther 5 5 (2005) 791-800
8. Daniell M.D., and Hill J.S. A history of photodynamic therapy. Aust N Z J Surg 61 5 (1991) 340-348
9. Dougherty T.J. A brief history of clinical photodynamic therapy development at Roswell Park Cancer Institute. J Clin Laser Med Surg 14 5 (1996) 219-221
10. Wilson B.D., Mang T.S., Stoll H., et al. Photodynamic therapy for the treatment of basal cell carcinoma. Arch Dermatol 128 12 (1992) 1597-1601
11. Jones C.M., Mang T., Cooper M., et al. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol 27 (1992) 979-982
12. Oseroff A.R., Blumenson L.E., Wilson B.D., et al. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin?) for treatment of basal cell carcinoma. Lasers Med Sci 38 5 (2006) 417-426
13. Kennedy J.C., Pottier R.H., and Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6 1-2 (1990) 143-148
14. Gollnick S.O., Liu X., Owczarczak B., et al. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res 57 18 (1997) 3904-3909
15. Oseroff A.R. PDT as a cytotoxic agent and biological response modifier: implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. J Invest Dermatol 126 3 (2006) 542-544
16. Morton C.A. Photodynamic therapy for nonmelanoma skin cancer-and more?. Arch Dermatol 140 1 (2004) 116-120
17. Rittenhouse-Diakun K., van Leengoed H., Morgan J., et al. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA). Photochem Photobiol 61 5 (1995) 523-528
18. Oseroff A.R., Shieh S., Frawley N.P., et al. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol 141 1 (2005) 60-67
19. Morton C.A., MacKie R.M., Whitehurst C., et al. Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. Arch Dermatol 134 2 (1998) 248-249
20. Stefanidou M., Tosca A., Themelis G., et al. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy. Eur J Dermatol 10 5 (2000) 351-356
21. Kuijpers D.I., Thissen M.R., Thissen C.A., et al. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. J Drugs Dermatol 5 7 (2006) 642-645
22. Lui H., Hobbs L., Tope W.D., et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes. Arch Dermatol 140 1 (2004) 26-32
23. Morton C.A., Whitehurst C., Moore J.V., et al. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 143 4 (2000) 767-772
24. Morton C.A., Whitehurst C., McColl J.H., et al. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol 137 3 (2001) 319-324
25. Babilas P., Kohl E., Maisch T., et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol 154 4 (2006) 712-718
26. Clark C., Bryden A., Dawe R., et al. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 19 3 (2003) 134-141
27. Britton J.E., Goulden V., Stables G., et al. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Br J Dermatol 153 4 (2005) 780-784
28. Wang I., Bendsoe N., Klinteberg C.A., et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 144 4 (2001) 832-840
29. Fink-Puches R., Soyer H.P., Hofer A., et al. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. Arch Dermatol 134 7 (1998) 821-826
30. Haller J.C., Cairnduff F., Slack G., et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 143 6 (2000) 1270-1275
31. Thissen M.R., Schroeter C.A., and Neumann H.A. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 142 2 (2000) 338-339
32. Barlow J.O., Zalla M.J., Kyle A., et al. Treatment of basal cell carcinoma with curettage alone. J Am Acad Dermatol 54 6 (2006) 1039-1045
33. Rhodes L.E., Tsoukas M.M., Anderson R.R., et al. Iontophoretic delivery of ALA provides a quantitative model for ALA pharmacokinetics and PpIX phototoxicity in human skin. J Invest Dermatol 108 1 (1997) 87-91
34. Choudry K., Brooke R.C., Farrar W., et al. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 149 1 (2003) 124-130
35. Cappugi P., Mavilia L., Campolmi P., et al. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid. J Chemother 16 5 (2004) 491-493
36. de Blois A.W., Grouls R.J., Ackerman E.W., et al. Development of a stable solution of 5-aminolaevulinic acid for intracutaneous injection in photodynamic therapy. Lasers Med Sci 17 3 (2002) 208-215
37. Kuijpers D.I., Smeets N.W., Krekels G.A., et al. Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with Mohs micrographic surgery. Dermatol Surg 30 5 (2004) 794-798
38. Itkin A., and Gilchrest B.A. Delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg 30 7 (2004) 1054-1061
39. Morton C.A., Whitehurst C., Moseley H., et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 135 5 (1996) 766-771
40. Salim A., Leman J.A., McColl J.H., et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 148 3 (2003) 539-543
41. Alexiades-Armenakas M.R., and Geronemus R.G. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 139 10 (2003) 1313-1320
42. Girardi M., Heald P.W., and Wilson L.D. The pathogenesis of mycosis fungoides. N Engl J Med 350 19 (2004) 1978-1988
43. Coors E.A., and von den Driesch P. Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol 50 3 (2004) 363-367
44. Edstrom D.W., Porwit A., and Ros A.M. Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response. Acta Derm Venereol 81 3 (2001) 184-188
45. Orenstein A., Haik J., Tamir J., et al. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application. Dermatol Surg 26 8 (2000) 765-769
46. Markham T., Sheahan K., and Collins P. Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides. Br J Dermatol 144 6 (2001) 1262-1263
47. Mori M., Campolmi P., Mavilia L., et al. Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study. J Am Acad Dermatol 54 3 (2006) 524-526
48. Umegaki N., Moritsugu R., Katoh S., et al. Photodynamic therapy may be useful in debulking cutaneous lymphoma prior to radiotherapy. Clin Exp Dermatol 29 1 (2004) 42-45
49. Shieh S., Dee A.S., Cheney R.T., et al. Photodynamic therapy for the treatment of extramammary Paget's disease. Br J Dermatol 146 6 (2002) 1000-1005
50. Tulchinsky H., Zmora O., Brazowski E., et al. Extramammary Paget's disease of the perianal region. Colorectal Dis 6 3 (2004) 206-209
51. Fritsch C., Lang K., Neuse W., et al. Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol Appl Skin Physiol 11 6 (1998) 358-373
52. Stender I.M., Bech-Thomsen N., Poulsen T., et al. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol 66 4 (1997) 493-496
53. Sharfaei S., Viau G., Lui H., et al. Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice. Br J Dermatol 144 6 (2001) 1207-1214
54. de Graaf Y.G., Kennedy C., Wolterbeek R., et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 126 3 (2006) 569-574
55. Dragieva G., Hafner J., Dummer R., et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 77 1 (2004) 115-121
56. Morton C., Whitehurst C., McColl J.H., et al. Photodynamic therapy for large or multiple patches of Bowen Disease and basal cell carcinoma. Arch Dermatol 137 (2001) 319-324